US FDA grants EIR to Lupin’s Ankleshwar manufacturing facility
The inspection of the facility was conducted from 16th to 19th August, 2022
The US Food and Drug Administration (FDA) has granted Establishment Inspection Report (EIR) to Lupin’s Ankleshwar manufacturing facility, located in Gujarat, according to a statement by Lupin.
The statement informed that the inspection of the facility was conducted from 16th to 19th August, 2022.
- Advertisement -
Your blog is very informative. thanks for Sharing this blog.